INTRAVENOUS LORAZEPAM TO PREVENT NAUSEA AND VOMITING ASSOCIATED WITH CANCER CHEMOTHERAPY

作者: Jane Maher

DOI: 10.1016/S0140-6736(81)90019-2

关键词:

摘要:

参考文章(8)
RICHARD B. KNAPP, LOUIS FIERRO, Evaluation of the cardiopulmonary safety and effects of lorazepam as a premedicant. Anesthesia & Analgesia. ,vol. 53, pp. 122- ,(1974) , 10.1213/00000539-197401000-00031
A. E. Larking, PART-TIME MEDICAL OFFICERS OF HEALTH BMJ. ,vol. 1, pp. 476- 476 ,(1910) , 10.1136/BMJ.1.2564.476
Stephen E. Sallan, Carol Cronin, Marvin Zelen, Norman E. Zinberg, Antiemetics in Patients Receiving Chemotherapy for Cancer New England Journal of Medicine. ,vol. 302, pp. 135- 138 ,(1980) , 10.1056/NEJM198001173020302
MICHAEL JOHNSTONE, The effect of lorazepam on the vasoconstriction of fear Anaesthesia. ,vol. 31, pp. 868- 872 ,(1976) , 10.1111/J.1365-2044.1976.TB11897.X
C. Guilleminault, R. A. Wilson, W. C. Dement, A Study on Cataplexy JAMA Neurology. ,vol. 31, pp. 255- 261 ,(1974) , 10.1001/ARCHNEUR.1974.00490400069008
Yoss Re, The inheritance of diurnal sleepiness as measured by pupillography. Mayo Clinic proceedings. ,vol. 45, pp. 426- ,(1970)
Vincent Zarcone, Narcolepsy New England Journal of Medicine. ,vol. 288, pp. 1156- 1166 ,(1973) , 10.1056/NEJM197305312882205